Cibc World Mkts upgraded shares of kneat.com (TSE:KSI - Free Report) to a strong-buy rating in a research report report published on Tuesday morning, Zacks.com reports.
Other analysts have also recently issued reports about the stock. Ventum Cap Mkts upgraded shares of kneat.com to a "strong-buy" rating in a research note on Wednesday, August 7th. CIBC set a C$6.00 price target on shares of kneat.com and gave the company an "outperform" rating in a research note on Tuesday.
Read Our Latest Stock Report on KSI
kneat.com Stock Performance
KSI traded down C$0.10 during midday trading on Tuesday, reaching C$4.70. The company had a trading volume of 15,458 shares, compared to its average volume of 55,854. The company has a debt-to-equity ratio of 95.14, a quick ratio of 1.50 and a current ratio of 1.47. The stock has a market cap of C$404.20 million, a PE ratio of -29.38, a P/E/G ratio of 597.67 and a beta of 1.08. kneat.com has a 12-month low of C$2.68 and a 12-month high of C$5.17. The business has a 50-day moving average price of C$4.76 and a two-hundred day moving average price of C$4.44.
kneat.com (TSE:KSI - Get Free Report) last released its earnings results on Tuesday, August 6th. The company reported C($0.04) earnings per share for the quarter, meeting analysts' consensus estimates of C($0.04). The firm had revenue of C$11.68 million for the quarter, compared to analysts' expectations of C$11.45 million. kneat.com had a negative net margin of 31.19% and a negative return on equity of 51.13%. On average, sell-side analysts expect that kneat.com will post -0.12 earnings per share for the current fiscal year.
About kneat.com
(
Get Free Report)
kneat.com, inc., together with its subsidiaries, designs, develops, and supplies software for data and document management within regulated environments in North America, Europe, and the Asia Pacific. The company offers the Kneat Gx platform, a configurable off-the-shelf application focused on validation lifecycle management and testing for biotechnology, pharmaceutical, and medical device manufacturing industries.
Read More
Before you consider kneat.com, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and kneat.com wasn't on the list.
While kneat.com currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
